The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
© 2024 TheOutpost.AI All rights reserved
Curated by THEOUTPOST
On July 22, 2024
3 Sources
[1]
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners
Delivering integrated, AI-enabled solutions specifically designed for patent preparation and prosecution , /CNW/ -- (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it has acquired through a subsidiary. is the provider of Rowan Patents - an integrated patent drafting and prosecution solution specially designed for patent practitioners to establish and protect patents more effectively. Clarivate enables organizations worldwide to confidently create, manage and protect critical intellectual property assets with solutions for the entire IP lifecycle. This acquisition will enable Clarivate to extend its workflow automation solutions beyond its market-leading IP management and intelligence capabilities, delivering new comprehensive and integrated solutions to support patent preparation, filing and prosecution. It also positions Clarivate to provide patent practitioners in this emerging market with automation and responsible artificial intelligence (AI) - enabled solutions that facilitate the efficient delivery of high-quality patent applications. , President, Intellectual Property, Clarivate, said: "Clarivate is committed to simplifying and optimizing IP management, empowering organizations to protect, manage, and leverage their IP assets in an increasingly competitive and global market. Rowan Patents will help Clarivate bring together AI and intelligent automation tools to support critical attorney tasks. This combination will help us advance our strategy to become the central hub for IP management, by delivering an integrated end-to-end workspace for patent practitioners." Clarivate has been expanding software support across the IP lifecycle and making ongoing enhancements to its leading patent maintenance, IP management software (IPMS), and IP intelligence capabilities. As part of this strategy, Clarivate announced the launch of IP Collaboration Hub in June. To drive innovation in IP management and decision making, Clarivate develops purpose-driven, responsible AI solutions. , CEO of Rowan TELS, said: "With its unmatched IP Solutions and deep expertise, Clarivate is well positioned to bring Rowan's advanced technologies, including generative AI, to enhance complex patent preparation and prosecution. The Rowan team is excited to help Clarivate deliver new end-to-end workspace solutions that will empower IP practitioners to create quality patents." About Clarivate Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com About Rowan TELS Rowan TELS provides software that brings automation, AI, and workflow solutions to address the complex legal challenges of corporations and law firms. Rowan Patents is an integrated patent drafting environment that provides all the elements to draft a patent - claims and specifications as well as drawings, chemical structures, and biological sequences - in one product, synchronized and linked together to ensure consistency. Rowan Patents helps professionals complete their goals more efficiently, with fewer errors and better quality. This is done by reducing the tedious, time-consuming tasks that account for a significant amount of patent practitioner time so they can focus on drafting and prosecuting meaningful patents. View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-acquires-rowan-tels-to-enhance-support-for-patent-practitioners-302202378.html
[2]
Clarivate Buys Rowan TELS
(RTTNews) - Clarivate Plc. (CLVT), a provider of transformative intelligence, announced on Monday that it has acquired Rowan TELS Corp. through a subsidiary. Rowan TELS is the provider of Rowan Patents, an integrated patent drafting and prosecution solution to support patent practitioners to establish and protect patents more effectively. Clarivate supports the companies to confidently create, manage, and protect critical intellectual property assets with solutions for the entire IP lifecycle. This acquisition will enable Clarivate to extend its workflow automation solutions beyond its market- IP management and intelligence capabilities to support patent preparation, filing and prosecution. In addition, Clarivate will be able to provide patent practitioners in this emerging market with automation and responsible AI- enabled solutions to facilitate the efficient delivery of high-quality patent applications. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
[3]
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners | Taiwan News | Jul. 22, 2024 18:00
Delivering integrated, AI-enabled solutions specifically designed for patent preparation and prosecution LONDON, July 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it has acquired Rowan TELS Corp. through a subsidiary. Rowan TELS Corp. is the provider of Rowan Patents - an integrated patent drafting and prosecution solution specially designed for patent practitioners to establish and protect patents more effectively. Clarivate enables organizations worldwide to confidently create, manage and protect critical intellectual property assets with solutions for the entire IP lifecycle. This acquisition will enable Clarivate to extend its workflow automation solutions beyond its market-leading IP management and intelligence capabilities, delivering new comprehensive and integrated solutions to support patent preparation, filing and prosecution. It also positions Clarivate to provide patent practitioners in this emerging market with automation and responsible artificial intelligence (AI) - enabled solutions that facilitate the efficient delivery of high-quality patent applications. Gordon Samson, President, Intellectual Property, Clarivate, said: "Clarivate is committed to simplifying and optimizing IP management, empowering organizations to protect, manage, and leverage their IP assets in an increasingly competitive and global market. Rowan Patents will help Clarivate bring together AI and intelligent automation tools to support critical attorney tasks. This combination will help us advance our strategy to become the central hub for IP management, by delivering an integrated end-to-end workspace for patent practitioners." Clarivate has been expanding software support across the IP lifecycle and making ongoing enhancements to its leading patent maintenance, IP management software (IPMS), and IP intelligence capabilities. As part of this strategy, Clarivate announced the launch of IP Collaboration Hub in June. To drive innovation in IP management and decision making, Clarivate develops purpose-driven, responsible AI solutions. John Amster, CEO of Rowan TELS, said: "With its unmatched IP Solutions and deep expertise, Clarivate is well positioned to bring Rowan's advanced technologies, including generative AI, to enhance complex patent preparation and prosecution. The Rowan team is excited to help Clarivate deliver new end-to-end workspace solutions that will empower IP practitioners to create quality patents." About Clarivate Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com About Rowan TELS Rowan TELS provides software that brings automation, AI, and workflow solutions to address the complex legal challenges of corporations and law firms. Rowan Patents is an integrated patent drafting environment that provides all the elements to draft a patent - claims and specifications as well as drawings, chemical structures, and biological sequences - in one product, synchronized and linked together to ensure consistency. Rowan Patents helps professionals complete their goals more efficiently, with fewer errors and better quality. This is done by reducing the tedious, time-consuming tasks that account for a significant amount of patent practitioner time so they can focus on drafting and prosecuting meaningful patents. Media contact Jack Wan External Communications Director, Clarivate [email protected]
Share
Share
Copy Link
Clarivate, a global leader in analytics and information services, has acquired Rowan TELS, a provider of patent drafting and portfolio management software. This strategic move aims to enhance Clarivate's support for patent practitioners and streamline the patent application process.
Clarivate Plc, a prominent global leader in analytics and information services, has announced its acquisition of Rowan TELS, a company specializing in patent drafting and portfolio management software 1. The financial terms of the deal have not been disclosed, maintaining confidentiality around the transaction 2.
This acquisition is a strategic move by Clarivate to enhance its support for patent practitioners and streamline the patent application process. By integrating Rowan TELS' software into its existing suite of intellectual property solutions, Clarivate aims to provide a more comprehensive and efficient service to its clients 1.
Rowan TELS is known for its innovative software solutions that assist in patent drafting and portfolio management. Their tools are designed to improve the efficiency and accuracy of patent applications, which aligns well with Clarivate's mission to provide cutting-edge solutions in the intellectual property space 3.
The acquisition is expected to significantly bolster Clarivate's existing intellectual property solutions. By incorporating Rowan TELS' technology, Clarivate will be able to offer enhanced services to patent attorneys, IP professionals, and organizations involved in patent prosecution and portfolio management 1.
Following the announcement, Clarivate's stock showed a positive response. The company's shares were up 1.5% in pre-market trading on the New York Stock Exchange, indicating investor optimism about the acquisition and its potential benefits for Clarivate's business 2.
This acquisition reflects a broader trend in the intellectual property services industry, where companies are increasingly looking to provide end-to-end solutions for patent practitioners. By combining advanced analytics with specialized software tools, firms like Clarivate are positioning themselves to meet the evolving needs of the IP market 3.
The integration of Rowan TELS into Clarivate's operations is expected to yield synergies that will benefit both companies' existing clients. As the intellectual property landscape continues to evolve, this acquisition positions Clarivate to better serve its global customer base and potentially capture a larger market share in the patent services industry 1.
Reference
[1]
[2]
Clarivate has launched a new AI-powered research tool called Primo Research Assistant, designed to enhance academic research and maintain integrity in higher education institutions.
3 Sources
Clarivate, a global leader in analytics and insights, has launched a new generative AI-powered research assistant for its Web of Science platform, aiming to revolutionize the way researchers interact with scientific literature.
2 Sources
A new report by Clarivate reveals how artificial intelligence is reshaping the future of libraries. The study explores AI's potential to enhance library services, improve resource management, and redefine the role of librarians.
2 Sources
Clarivate, a global leader in analytics, has unveiled its annual list of Citation Laureates for 2024. These researchers, whose work has been highly cited, are considered likely contenders for future Nobel Prizes.
2 Sources
Exscientia, a leading AI-driven pharmatech company, has acquired full rights to a potential best-in-class CDK7 inhibitor for cancer treatment. The move has been met with positive analyst reactions and a buy rating.
3 Sources